0001144204-19-035673 Sample Contracts

MOLECULIN BIOTECH, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement

Moleculin Biotech, Inc. • July 24th, 2019 • Pharmaceutical preparations • New York

• Company
  Moleculin Biotech, Inc.
• Filed
  July 24th, 2019
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Moleculin Biotech, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with Oppenheimer & Co. Inc. (the “Agent”) as follows: